Omega Fund Management as of June 30, 2016
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Juno Therapeutics | 35.1 | $47M | 1.2M | 38.44 | |
| Paratek Pharmaceuticals | 26.8 | $36M | 2.6M | 13.91 | |
| Egalet | 10.6 | $14M | 2.9M | 4.96 | |
| Fibrogen (FGEN) | 10.0 | $14M | 822k | 16.41 | |
| Nabriva Therapeutics | 6.4 | $8.6M | 1.1M | 7.50 | |
| Essa Pharma | 3.7 | $5.0M | 1.7M | 2.95 | |
| Pieris Pharmaceuticals | 2.7 | $3.6M | 2.3M | 1.61 | |
| Editas Medicine (EDIT) | 1.9 | $2.6M | 105k | 24.40 | |
| Proteon Therapeutics | 1.5 | $2.0M | 250k | 8.03 | |
| Cymabay Therapeutics | 0.8 | $1.1M | 606k | 1.74 | |
| Dicerna Pharmaceuticals | 0.5 | $670k | 224k | 3.00 |
